Position in MESO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$102,230
-$20,369 QoQ
Shares Held
6,647
-2.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MESO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026QUADRANT CAPITAL GROUP LLC holds $22,161,348 across 129 Biotechnology names. MESO ranks #29 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,677 | $2,840,997 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,716 | $2,552,422 | |
| 3 | ARGX |
Argenx SE
|
2,778 | $2,028,634 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,605 | $1,363,639 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
49,144 | $1,361,288 | |
| 6 | EXEL |
Exelixis, Inc.
|
28,474 | $1,221,249 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
20,772 | $1,173,410 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
5,659 | $1,129,819 |
All Filings in MESO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $102,230 | 6,647 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $122,599 | 6,796 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $113,269 | 7,031 | Shares | Sole | 2025-11-13 | |
| 2025-03-31 | $81,519 | 6,532 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $128,620 | 6,496 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $37,622 | 4,605 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $40,131 | 5,893 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||